Finance News
Q2 update reinforces the central NRXP investment thesis: preservative-free ketamine is moving toward commercialization while NRX-101, DARPA funding, HOPE Therapeutics and a stronger balance sheet create multiple potential catalysts.
Affluence Corporation (Stock Symbol: AFFU) $AFFU Delivers AI-Enabled IoT, 5G and Data Visualization Platform;s to Enterprise and Municipal Clients Worldwide
MBody AI Corp / Check-Cap Ltd. (NAS DAQ: MBAI) $MBAI Operates in the $16 Billion 2026 North American Service Robotics Market Projected to Reach $29 Billion by 2031
First-cycle FDA review delivers one of the strongest signals yet that NRx's preservative-free ketamine opportunity may be entering its final stretch, while the company's broader neuropsychiatric pipeline continues to gain momentum.
Today's Commercial Expansion, Growing Enterprise Deployments and Accelerating Merger Timeline Position MBody AI $MBAI to Capitalize on the Rapidly Emerging Multi-Trillion-Dollar Embodied AI Revolution
Leading Innovators in the Emerging AUV/Drone Sector Include ZenaTech (N A S D A Q: ZENA) $ZENA, Draganfly (N A S D A Q: DPRO) $DRPO, Quantum Cyber N.V. (N A S D A Q: QUCY) $QUCY, Unusual Machines, (N YS E American: UMAC) $UMAC, Safe Pro Group Inc. (N A S
Record financial performance, expanding European government partnerships, and an integrated technology platform position Circle8 Group $CIRC for its next phase of long-term growth.
With 640% first-quarter revenue growth, a rapidly expanding Drone-as-a-Service platform, strategic acquisitions across North America, AI and quantum computing initiatives, and growing defense opportunities, ZenaTech $ZENA is executing an ambitious strateg